Thu, 05 Dec 2024
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC| About | Newsletters | Transcripts
Business News Top © 2024-2025